Oruka Therapeutics, Inc.

Q3 2024 13F Holders

Symbol
ORKA
CUSIP
687604108
Type
Equity
Class
COM
Num filings
44
Total reported value, excl. options
$604 M
Manager Report Date Value ($000) Shares Option Type